TABLE 1.
Sequence | Recommended use |
---|---|
T1-weighted turbo spin echo | Evaluation of cortex (normally dark) and marrow infiltration (marrow darker than normal) |
Contrast-enhanced T2-weighted fat suppression | Evaluation for marrow edema and replacement; a T2-weighted fat-suppressed sequence (areas of edema and replacement are often brighter than background fat-containing marrow) |
T2-weighted half-Fourier acquisition single-shot fast spin echo | Evaluation of the full body and anatomic detail on organs and soft tissues; a fast-acquisition T2-weighted sequence |
ADC DWI* Evaluation | of lesion cellularity; a possible biomarker of treatment response |
DCE MRI* | Evaluation of limited regions such as in the case of a plasmacytoma; a surrogate for perfusion and permeability |
Attenuation-corrected T1-weighted Dixon | Creation of a μ-map for attenuation correction of PET data; a dual-echo gradient recalled echo sequence that is acquired at in-phase and opposed-phase echo times with generation of fat-only and water-only images |
ADC DWI and DCE MRI sequences may be applied in a more focused way to characterize specific sites of disease and potentially add value in assessing tumor response. DCE is not a WB method.